119 related articles for article (PubMed ID: 31968989)
1. Chemotherapy Near the End of Life in Onco-Hematological Adult Patients.
Sánchez-Cuervo M; García-Basas L; Gómez de Salazar-López de Silanes E; Pueyo-López C; Bermejo-Vicedo T
Am J Hosp Palliat Care; 2020 Aug; 37(8):641-647. PubMed ID: 31968989
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy near the end of life; assessment of the clinical practise in onco-hematological in adult patients.
Taberner Bonastre P; Taberner Bonastre MT; Soler Company E; Pérez-Serrano Lainosa MD
Farm Hosp; 2016 Jan; 40(1):14-24. PubMed ID: 26882830
[TBL] [Abstract][Full Text] [Related]
3. Intensity of Cancer Care Near the End of Life at a Tertiary Care Cancer Center in Jordan.
Abdel-Razeq H; Shamieh O; Abu-Nasser M; Nassar M; Samhouri Y; Abu-Qayas B; Asfour J; Jarrah J; Abdelrahman Z; Ameen Z; Al-Hawamdeh A; Alomari M; Al-Tabba' A; Al-Rimawi D; Hui D
J Pain Symptom Manage; 2019 Jun; 57(6):1106-1113. PubMed ID: 30802634
[TBL] [Abstract][Full Text] [Related]
4. Targeted agent use in cancer patients at the end of life.
Hui D; Karuturi MS; Tanco KC; Kwon JH; Kim SH; Zhang T; Kang JH; Chisholm G; Bruera E
J Pain Symptom Manage; 2013 Jul; 46(1):1-8. PubMed ID: 23211648
[TBL] [Abstract][Full Text] [Related]
5. Hospital end-of-life care in haematological malignancies.
Beaussant Y; Daguindau E; Chauchet A; Rochigneux P; Tournigand C; Aubry R; Morin L
BMJ Support Palliat Care; 2018 Sep; 8(3):314-324. PubMed ID: 29434048
[TBL] [Abstract][Full Text] [Related]
6. Palliative Chemotherapy Near the End of Life in Oncology Patients.
Zhang Z; Chen ML; Gu XL; Liu MH; Zhao WW; Cheng WW
Am J Hosp Palliat Care; 2018 Sep; 35(9):1215-1220. PubMed ID: 29529885
[TBL] [Abstract][Full Text] [Related]
7. Use of chemotherapy near the end of life: what factors matter?
Rochigneux P; Raoul JL; Beaussant Y; Aubry R; Goldwasser F; Tournigand C; Morin L
Ann Oncol; 2017 Apr; 28(4):809-817. PubMed ID: 27993817
[TBL] [Abstract][Full Text] [Related]
8. [Chemotherapy at the end of life: Uncommon clinical practice?].
Santos Pérez MI; Godoy Díez M; Abajo Del Álamo C
J Healthc Qual Res; 2019; 34(4):201-207. PubMed ID: 31713531
[TBL] [Abstract][Full Text] [Related]
9. Intensive palliative care for patients with hematological cancer dying in hospice: analysis of the level of medical care in the final week of life.
Cheng BH; Sham MM; Chan KY; Li CW; Au HY
Am J Hosp Palliat Care; 2015 Mar; 32(2):221-5. PubMed ID: 24259405
[TBL] [Abstract][Full Text] [Related]
10. [Palliative care for children in onco-hematology: Role of a specific home-care team].
Bertrand A; Marcault-Derouard A; Devaux Y; Bertrand Y; Bergeron C; Veyet V; Cervos M; Filion S; Goy F; Schell M
Bull Cancer; 2018 Sep; 105(9):771-779. PubMed ID: 30251628
[TBL] [Abstract][Full Text] [Related]
11. End-of-life care for hospitalized patients with metastatic melanoma in France: a nationwide, register-based study.
Gallais Sérézal I; Beaussant Y; Rochigneux P; Tournigand C; Aubry R; Lindelöf B; Morin L
Br J Dermatol; 2016 Sep; 175(3):583-92. PubMed ID: 27038100
[TBL] [Abstract][Full Text] [Related]
12. Reduced use of chemotherapy at the end of life in an integrated-care model of oncology and palliative care.
Magarotto R; Lunardi G; Coati F; Cassandrini P; Picece V; Ferrighi S; Oliosi L; Venturini M
Tumori; 2011; 97(5):573-7. PubMed ID: 22158486
[TBL] [Abstract][Full Text] [Related]
13. Association between palliative care and end-of-Life care for patients with hematological malignancies: A population-based study.
Chiang JK; Lee YC; Kao YH
Medicine (Baltimore); 2019 Oct; 98(40):e17395. PubMed ID: 31577748
[TBL] [Abstract][Full Text] [Related]
14. End-of-Life Trajectories of Patients With Hematological Malignancies and Patients With Advanced Solid Tumors Visiting the Emergency Department: The Need for a Proactive Integrated Care Approach.
Verhoef MJ; de Nijs EJM; Ootjers CS; Fiocco M; Fogteloo AJ; Heringhaus C; Marijnen CAM; Horeweg N; der Linden YMV
Am J Hosp Palliat Care; 2020 Sep; 37(9):692-700. PubMed ID: 31867978
[TBL] [Abstract][Full Text] [Related]
15. Is specialized palliative cancer care associated with use of antineoplastic treatment at the end of life? A population-based cohort study.
Skov Benthien K; Adsersen M; Petersen MA; Soelberg Vadstrup E; Sjøgren P; Groenvold M
Palliat Med; 2018 Oct; 32(9):1509-1517. PubMed ID: 30004303
[TBL] [Abstract][Full Text] [Related]
16. Timing of palliative care needs reporting and aggressiveness of care near the end of life in metastatic lung cancer: A national registry-based study.
Goldwasser F; Vinant P; Aubry R; Rochigneux P; Beaussant Y; Huillard O; Morin L
Cancer; 2018 Jul; 124(14):3044-3051. PubMed ID: 29742292
[TBL] [Abstract][Full Text] [Related]
17. Experiences with Prescribing Large Quantities of Systemic Anticancer Therapy Near Death.
Baena-Cañada JM; Campini Bermejo A; Gámez Casado S; Rodríguez Pérez L; Quílez Cutillas A; Calvete Candenas J; Martínez Bautista MJ; Benítez Rodríguez E
J Palliat Med; 2019 Dec; 22(12):1515-1521. PubMed ID: 31184989
[No Abstract] [Full Text] [Related]
18. Chemotherapy at the End of Life.
Urvay S; Civelek B; Özaslan E; Sürel AA
J Palliat Care; 2021 Apr; 36(2):73-77. PubMed ID: 32762320
[TBL] [Abstract][Full Text] [Related]
19. Psychological factors at early stage of treatment as predictors of receiving chemotherapy at the end of life.
Fujisawa D; Temel JS; Traeger L; Greer JA; Lennes IT; Mimura M; Pirl WF
Psychooncology; 2015 Dec; 24(12):1731-7. PubMed ID: 25959002
[TBL] [Abstract][Full Text] [Related]
20. The aggressiveness of cancer care in the last three months of life: a retrospective single centre analysis.
Braga S; Miranda A; Fonseca R; Passos-Coelho JL; Fernandes A; Costa JD; Moreira A
Psychooncology; 2007 Sep; 16(9):863-8. PubMed ID: 17245696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
